CDKN2A and breast cancer: Since the cell lines used harbour mutations in various genes such as PTEN, TP53, PIK3CA, KRAS, HRAS, CDKN2A, or TERT [53,54], our data suggest that KMT9 controls the proliferation and migration of BC cells regardless of the mutation profile.